Literature DB >> 2055865

Pulmonary vascular reactivity in Fischer rats.

L S He1, S W Chang, N F Voelkel.   

Abstract

We previously reported that Fischer (F) rat lungs developed more extensive injury when challenged with oxidants than age-matched Sprague-Dawley (SD) rat lungs. We now describe a reduced pulmonary vascular response to alveolar hypoxia and angiotensin II (ANG II) in F compared with SD rats. The comparative studies were performed with isolated lungs perfused with salt solution or blood, catheter-implanted awake rats, and isolated main pulmonary arterial rings. Isolated lungs from F rats perfused with either blood or salt solution had reduced vasoconstriction in comparison with lungs from SD rats when exposed to alveolar hypoxia or challenged with ANG II. Instrumented awake F rats had a smaller mean increase in total pulmonary vascular resistance (PVR) than SD rats (35 vs. 94 mmHg.min.l-1, P less than 0.05) when challenged with 8% oxygen. The contractile response of isolated pulmonary artery but not thoracic aortic rings to KCl and ANG II was reduced in F compared with SD rats. In addition, F rats exposed to 4 wk of hypobaric hypoxia developed less pulmonary hypertension and right ventricular hypertrophy (when corrected for the hematocrit) than SD rats. We conclude that the oxidant stress-sensitive inbred F rat strain is characterized by a lung vascular bed that is relatively unresponsive to vasoconstricting stimuli. The mechanism underlying this genetic difference in lung vascular control remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055865     DOI: 10.1152/jappl.1991.70.4.1861

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

Review 1.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 2.  Plexiform Arteriopathy in Rodent Models of Pulmonary Arterial Hypertension.

Authors:  Brandon L Carman; Dan N Predescu; Roberto Machado; Sanda A Predescu
Journal:  Am J Pathol       Date:  2019-03-26       Impact factor: 4.307

3.  Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.

Authors:  Chun Zhou; Mary I Townsley; Mikhail Alexeyev; Norbert F Voelkel; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-15       Impact factor: 5.464

4.  Effect of Cocaine on Pulmonary Vascular Remodeling and Hemodynamics in Human Immunodeficiency Virus-Transgenic Rats.

Authors:  Pranjali Dalvi; Leslie Spikes; Julie Allen; Vijayalaxmi G Gupta; Himanshu Sharma; Marion Gillcrist; Jamison Montes de Oca; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

6.  Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse.

Authors:  Himanshu Sharma; Mahendran Chinnappan; Stuti Agarwal; Pranjali Dalvi; Sumedha Gunewardena; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  FASEB J       Date:  2018-04-19       Impact factor: 5.191

Review 7.  Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Abdirashit Maripov; Djuro Kosanovic; Norbert Weissmann; Hossein Ardeschir Ghofrani; Akpay Sh Sarybaev; Ralph Theo Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

8.  Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development.

Authors:  Kristi M Porter; Erik R Walp; Shawn C Elms; Robert Raynor; Patrick O Mitchell; David M Guidot; Roy L Sutliff
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

9.  Effects of bevacizumab administration on the hypoxia-induced pulmonary hypertension rat model.

Authors:  Canan Demir; Meral Karaman; Eyüp Sabri Uçan; Ali Necati Gökmen; Duygu Gürel; Şadiye Canan Çoker; Yasemen Adali; Osman Yilmaz
Journal:  Turk J Med Sci       Date:  2021-08-02       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.